Ceftriaxone (Cetrikast): Medication Overview
Ceftriaxone is a third-generation cephalosporin antibiotic administered intravenously or intramuscularly, typically dosed once daily due to its long half-life, and is highly effective against a broad spectrum of bacterial infections including meningitis, urinary tract infections, respiratory infections, and gonorrhea.
What is Ceftriaxone?
Ceftriaxone is a broad-spectrum cephalosporin antibiotic with enhanced activity against Gram-negative bacteria compared to earlier generation cephalosporins 1. It has a uniquely long half-life (5.4-10.9 hours) that allows for convenient once-daily dosing in most clinical situations 2.
Standard Dosing
Adults
- Typical infections: 1-2 grams IV/IM once daily (or divided twice daily)
- Maximum daily dose: 4 grams
- Meningitis: 2 grams IV every 12 hours (empiric therapy) 3
- Uncomplicated gonorrhea: Single 250 mg IM dose 1
- Surgical prophylaxis: Single 1 gram IV dose 30 minutes to 2 hours before surgery 1
Pediatric Patients
- Skin/soft tissue infections: 50-75 mg/kg once daily (max 2 grams) 1
- Acute otitis media: Single 50 mg/kg IM dose (max 1 gram) 1
- Serious infections (non-meningitis): 50-75 mg/kg daily divided every 12 hours (max 2 grams) 1
- Meningitis: Initial dose 100 mg/kg (max 4 grams), then 100 mg/kg/day once daily or divided every 12 hours for 7-14 days 4, 1
Neonates (Critical Precautions)
Ceftriaxone is contraindicated in premature neonates and in any neonate ≤28 days requiring calcium-containing IV solutions 1. When used in term neonates:
- Administer IV doses over 60 minutes (not 30 minutes) to reduce bilirubin encephalopathy risk 1
- For infants 22-60 days old with fever: 50 mg/kg IV/IM once daily 4
- Never use in hyperbilirubinemic neonates 1
Administration Routes
Intravenous (IV)
- Infuse over 30 minutes in adults and children 1
- Infuse over 60 minutes in neonates 1
- Concentrations between 10-40 mg/mL are recommended 1
- Compatible diluents: sterile water, 0.9% sodium chloride, 5% dextrose 1
Intramuscular (IM)
- Inject deep into large muscle mass 1
- Reconstitute to 250 mg/mL or 350 mg/mL concentration 1
- Can use 1% lidocaine (without epinephrine) as diluent for IM injection 1
Common Side Effects
Based on safety data from 2,640 patients 5:
- Gastrointestinal effects (3.45%): Diarrhea most common
- Hypersensitivity reactions (2.99%): Rash, pruritus
- Local reactions (1.86%): Pain at injection site, phlebitis (more common with twice-daily dosing)
- Laboratory abnormalities: Elevated liver transaminases (10% of patients) 6
Serious Adverse Effects (Rare but Important)
- Anaphylaxis: Rare but possible 4
- Immune hemolytic anemia: Can cause acute hemolysis with 24% mortality in historical cases (though declining to 18% in recent reports); requires immediate discontinuation 7
- Bilirubin encephalopathy: Risk in neonates, especially with rapid infusion 1
- Ceftriaxone-calcium precipitation: Fatal cases reported when mixed with calcium-containing solutions 1
Critical Precautions and Contraindications
Absolute Contraindications
- Premature neonates (any gestational age) 1
- Neonates ≤28 days requiring calcium-containing IV solutions 1
- Hyperbilirubinemic neonates 1
Drug Incompatibilities
Never mix or administer simultaneously with 1:
- Calcium-containing solutions (Ringer's, Hartmann's solution)
- Vancomycin (give sequentially with line flush between)
- Aminoglycosides (give sequentially with line flush between)
- Fluconazole (give sequentially with line flush between)
- Amsacrine (give sequentially with line flush between)
Special Populations
- Pregnancy: Safe to use; avoid quinolones and tetracyclines instead 8
- Renal/hepatic impairment: No dose adjustment needed unless severe combined impairment 1
- Elderly: No dose adjustment needed up to 2 grams daily if no severe organ dysfunction 1
Duration of Therapy
- Most infections: Continue for at least 2 days after clinical improvement; typical duration 4-14 days 1
- Streptococcus pyogenes infections: Minimum 10 days 1
- Meningitis: 7-14 days depending on organism and clinical response 4, 1
- Gonorrhea: Single dose 1
Clinical Efficacy
Ceftriaxone demonstrates 93% clinical response rates across various infections 6 and 94% bacteriological eradication of susceptible pathogens 6. Once-daily dosing is as effective as twice-daily dosing for most infections 9, 10, 2, with the exception that empiric meningitis treatment may benefit from twice-daily dosing initially 11, 12.
For bacterial meningitis in children, recent pharmacokinetic modeling suggests 100 mg/kg once daily achieves better CSF target attainment (88% PTA) compared to 50 mg/kg twice daily (53% PTA) at 24 hours 11, though both achieve 100% probability of target attainment at steady state.
Storage and Stability
- Store powder at 20-25°C (68-77°F), protected from light 1
- Once reconstituted, solutions remain stable:
- Color ranges from light yellow to amber (normal) 1
Key Clinical Pearls
- The long half-life allows once-daily dosing, improving convenience and potentially reducing IV line complications 9, 2
- Achieves therapeutic levels in CSF, making it excellent for meningitis 6
- No activity against Chlamydia trachomatis; add appropriate coverage if suspected 1
- Limited activity against Pseudomonas aeruginosa; not recommended as sole therapy for pseudomonal infections 2
- Mortality from ceftriaxone-associated hemolytic anemia has declined from 80% (1991-2000) to 18% (recent reports), likely due to earlier recognition 7